Take a look at our previous reports:

Equity components of the remuneration

Subscription rights awarded, exercised or expired

In 2022, we issued subscription right plans for the benefit of employees of the group and of Executive Committee members: Subscription Right Plan 2022 (A), Subscription Right Plan (B), Subscription Right Plan 2022 BE, Subscription Right Plan 2022 RMV and Subscription Right Plan 2022 ROW. Each subscription right gives the right to subscribe for one new Galapagos share. Our CEO was offered new subscription rights under Subscription Right Plan 2022 (B) and the members of the Executive Committee were offered new subscription rights under Subscription Right Plan 2022 BE, subject to acceptance. The final number of accepted subscription rights under Subscription Right Plan 2022 (B) was enacted by the notary deed of 25 March 2022 and under Subscription Right Plan 2022 BE by notary deeds of 7 July 2022 and 2 September 2022. The table below sets forth the numbers of subscription rights offered and accepted by the CEO and each other member of the Executive Committee in 2022, respectively under Subscription Right Plan 2022 (B) and Subscription Right Plan 2022 BE.

The main characteristics of the subscription right plans offered to the members of the Executive Committee are as follows:

  • The subscription rights are offered for no consideration;
  • The subscription rights typically have a lifetime of eight years and a vesting period of three years after the year of grant;
  • Good and bad leaver rules apply in case of termination prior to the end of the vesting period.

Under Subscription Right Plan 2022 (B), the subscription rights have a lifetime of eight years and an exercise price of €50.00. The subscription rights under Subscription Right Plan 2022 (B) vest only and fully on the first day of the fourth calendar year following the calendar year in which the grant was made. The subscription rights can in principle not be exercised prior to 1 January 2026.

Under Subscription Right Plan 2022 BE, the subscription rights have a lifetime of eight years and an exercise price of €57.46. For all the beneficiaries under the Subscription Right Plan 2022 BE, the subscription rights vest only and fully on the first day of the fourth calendar year following the calendar year in which the grant was made. The subscription rights can in principle not be exercised prior to 1 January 2026 and are not transferable. The table below sets forth the main characteristics for subscription right plans issued during previous years and 2022.

As from 1 January 2020, Galapagos no longer grants any subscription rights to members of the Board of Directors, taking into account the stricter rules of the Belgian Companies Code and provision 7.6 of the 2020 Code, which stipulates that non-executive directors should not be entitled to receive stock options. Prior to 2020, members of the Board of Directors were granted subscription rights and hence the table below also contains disclosures for Board members.

No subscription rights expired for members of the Board of Directors or Executive Committee in 2022.

The table below sets forth the subscription rights outstanding and exercisable per 31 December 2022 for the (former) members of the Board of Directors or Executive Committee, the subscription rights awarded to the (former) Executive Committee members during 2022 and exercised by the (former) members of the Board of Directors or Executive Committee in 2022:

 

Plan(1)

Grant date

Vesting period

Exercise period

Exercise price

Number of SRs out­standing per 31/12/
2022

Number of SRs exer­cisable per 31/12/
2022

SRs offered & accepted during 2022

SRs exercised during 2022

SRs expired in 2022

Directors(2)

Dr. Rasjesh Parekh

WP 2017

30/08/2017

36 months
1/36 per month

01/01/2021 – 16/05/2025

€80.57

15,000

15,000

 

 

0

WP 2018

24/08/2018

36 months
1/36 per month

01/01/2022 – 18/04/2026

€79.88

15,000

15,000

 

 

0

WP 2019

12/07/2019

36 months
1/36 per month

01/01/2023 – 10/04/2027

€95.11

15,000

 

 

 

0

Mr. Howard Rowe

WP 2014

25/07/2014

36 months
1/36 per month

01/01/2018 – 24/07/2022

€14.54

0

0

 

2,520

0

WP 2015

30/04/2015

36 months
1/36 per month

01/01/2019 – 29/04/2023

€28.75

2,520

2,520

 

 

0

WP 2015.B

02/03/2016

36 months
1/36 per month

02/03/2019 – 21/12/2023

€49.00

7,500

7,500

 

 

0

WP 2016

16/08/2016

36 months
1/36 per month

01/01/2020 – 31/05/2024

€46.10

7,500

7,500

 

 

0

WP 2017

30/08/2017

36 months
1/36 per month

01/01/2021 – 16/05/2025

€80.57

7,500

7,500

 

 

0

WP 2018

24/08/2018

36 months
1/36 per month

01/01/2022 – 18/04/2026

€79.88

7,500

7,500

 

 

0

WP 2019

12/07/2019

36 months
1/36 per month

01/01/2023 – 10/04/2027

€95.11

7,500

 

 

 

0

Ms. Katrine Bosley

WP 2015

30/04/2015

36 months
1/36 per month

01/01/2019 – 29/04/2023

€28.75

2,520

2,520

 

0

WP 2015.B

02/03/2016

36 months
1/36 per month

02/03/2019 – 21/12/2023

€49.00

7,500

7,500

 

 

0

WP 2016

16/08/2016

36 months
1/36 per month

01/01/2020 – 31/05/2024

€46.10

7,500

7,500

 

 

0

WP 2017

30/08/2017

36 months
1/36 per month

01/01/2021 – 16/05/2025

€80.57

7,500

7,500

 

 

0

WP 2018

24/08/2018

36 months
1/36 per month

01/01/2022 – 18/04/2026

€79.88

7,500

7,500

 

 

0

WP 2019

12/07/2019

36 months
1/36 per month

01/01/2023 – 10/04/2027

€95.11

7,500

 

 

 

0

Dr. Mary Kerr

WP 2017

30/08/2017

36 months
1/36 per month

01/01/2021 – 16/05/2025

€80.57

7,500

7,500

 

 

0

WP 2018

24/08/2018

36 months
1/36 per month

01/01/2022 – 18/04/2026

€79.88

7,500

7,500

 

 

0

WP 2019

12/07/2019

36 months
1/36 per month

01/01/2023 – 10/04/2027

€95.11

7,500

 

 

 

0

Mr. Peter Guenter

WP 2019

12/07/2019

36 months
1/36 per month

01/01/2023 – 10/04/2027

€95.11

7,500

 

 

0

 

 

 

 

 

 

 

 

 

 

 

Executive Committee members

Stoffels IMC BV, permanently represented by Dr. Paul Stoffels

SR Plan 2022 (B)

25/03/2022

100%
3rd year after year of grant 01/01/2026

01/01/2026 – 25/01/2030

€50.00

1,000,000

0

1,000,000

 

0

Mr. Onno van de Stolpe

WP 2014

14/10/2014

36 months
1/36 per month

01/01/2018 – 24/07/2022

€14.54

0

0

 

100,000

0

WP 2015

29/06/2015

36 months
1/36 per month

01/01/2019 – 29/04/2023

€28.75

0

0

 

100,000

0

WP 2015.B

02/03/2016

36 months
1/36 per month

02/03/2019 – 21/12/2023

€49.00

100,000

100,000

 

 

0

WP 2016

31/07/2016

36 months
1/36 per month

01/01/2020 – 31/05/2024

€46.10

100,000

100,000

 

 

0

WP 2017

30/08/2017

36 months
1/36 per month

01/01/2021 – 16/05/2025

€80.57

100,000

100,000

 

 

0

WP 2018

18/06/2018

36 months
1/36 per month

01/01/2022 – 18/04/2026

€79.88

100,000

100,000

 

 

0

WP 2019

12/07/2019

36 months
1/36 per month

01/01/2023 – 10/04/2027

€95.11

100,000

 

 

 

0

SR Plan 2020

16/06/2020

100%
3rd year after year of grant 01/01/2024

01/01/2024 – 17/04/2028

€168.42

85,000

 

 

 

0

SR Plan 2021 BE

18/08/2021

100%
3rd year after year of grant 01/01/2025

01/01/2025 – 30/04/2029

€64.76

85,000

 

 

 

0

Mr. Bart Filius

WP 2017

30/08/2017

100%
3rd year after year of grant 01/01/2021

01/01/2021 – 16/05/2025

€80.57

60,000

60,000

 

 

0

WP 2018

18/06/2018

100%
3rd year after year of grant 01/01/2022

01/01/2022 – 18/04/2026

€79.88

80,000

80,000

 

 

0

WP 2019

12/07/2019

100%
3rd year after year of grant 01/01/2023

01/01/2023 – 10/04/2027

€95.11

65,000

 

 

 

0

SR Plan 2020

16/06/2020

100%
3rd year after year of grant 01/01/2024

01/01/2024 – 17/04/2028

€168.42

50,000

 

 

 

0

SR Plan 2021 BE

18/08/2021

100%
3rd year after year of grant 01/01/2025

01/01/2025 – 30/04/2029

€64.76

50,000

 

 

 

0

SR Plan 2022 BE

02/09/2022

100%
3rd year after year of grant 01/01/2026

01/01/2026 – 06/05/2030

€57.46

68,000

 

68,000

 

0

Dr. Andre Hoekema

WP 2014

14/10/2014

100%
3rd year after year of grant 01/01/2018

01/01/2018 – 24/07/2022

€14.54

0

0

 

10,000

0

WP 2015

29/06/2015

100%
3rd year after year of grant 01/01/2019

01/01/2019 – 29/04/2023

€28.75

20,000

20,000

 

10,000

0

WP 2015.B

02/03/2016

100%
3rd year after year of grant 02/03/2019

02/03/2019 – 21/12/2023

€49.00

40,000

40,000

 

 

0

WP 2016

31/07/2016

100%
3rd year after year of grant 01/01/2020

01/01/2020 – 31/05/2024

€46.10

55,000

55,000

 

 

0

WP 2017

30/08/2017

100%
3rd year after year of grant 01/01/2021

01/01/2021 – 16/05/2025

€80.57

60,000

60,000

 

 

0

WP 2018

18/06/2018

100%
3rd year after year of grant 01/01/2022

01/01/2022 – 18/04/2026

€79.88

50,000

50,000

 

 

0

WP 2019

12/07/2019

100%
3rd year after year of grant 01/01/2023

01/01/2023 – 10/04/2027

€95.11

50,000

 

 

 

0

SR Plan 2020

16/06/2020

100%
3rd year after year of grant 01/01/2024

01/01/2024 – 17/04/2028

€168.42

30,000

 

 

 

0

SR Plan 2021 BE

18/08/2021

100%
3rd year after year of grant 01/01/2025

01/01/2025 – 30/04/2029

€64.76

30,000

 

 

 

0

Dr. Walid Abi–Saab

WP 2016.B

06/04/2017

100%
3rd year after year of grant 06/04/2020

06/04/2020 – 19/01/2025

€62.50

10,000

10,000

 

 

0

WP 2017

30/08/2017

100%
3rd year after year of grant 01/01/2021

01/01/2021 – 16/05/2025

€80.57

45,000

45,000

 

 

0

WP 2018

18/06/2018

100%
3rd year after year of grant 01/01/2022

01/01/2022 – 18/04/2026

€79.88

60,000

60,000

 

 

0

WP 2019

12/07/2019

100%
3rd year after year of grant 01/01/2023

01/01/2023 – 10/04/2027

€95.11

50,000

 

 

 

0

SR Plan 2020

23/06/2020

100%
3rd year after year of grant 01/01/2024

01/01/2024 – 17/04/2028

€168.42

40,000

 

 

 

0

SR Plan 2021 BE

18/08/2021

100%
3rd year after year of grant 01/01/2025

01/01/2025 – 30/04/2029

€64.76

40,000

 

 

 

0

SR Plan 2022 BE

02/09/2022

100%
3rd year after year of grant 01/01/2026

01/01/2026 – 06/05/2030

€57.46

32,000

 

32,000

 

 

Mr. Michele Manto

WP 2017

30/08/2017

100%
3rd year after year of grant 01/01/2021

01/01/2021 – 16/05/2025

€80.57

60,000

60,000

 

 

0

WP 2018

18/06/2018

100%
3rd year after year of grant 01/01/2022

01/01/2022 – 18/04/2026

€79.88

30,000

30,000

 

 

0

WP 2019

12/07/2019

100%
3rd year after year of grant 01/01/2023

01/01/2023 – 10/04/2027

€95.11

40,000

 

 

 

0

SR Plan 2020

16/06/2020

100%
3rd year after year of grant 01/01/2024

01/01/2024 – 17/04/2028

€168.42

30,000

 

 

 

0

SR Plan 2021 BE

02/07/2021

100%
3rd year after year of grant 01/01/2025

01/01/2025 – 30/04/2029

€64.76

30,000

 

 

 

0

SR Plan 2022 BE

02/09/2022

100%
3rd year after year of grant 01/01/2026

01/01/2026 – 06/05/2030

€57.46

24,000

 

24,000

 

0

(1)

Warrant Plan (WP) and Subscription Right Plan (SR Plan)

(2)

Dr. Dan Baker, Dr. Elisabeth Svanberg, Mr. Jérôme Contamine, Mr. Daniel O’Day and Dr. Linda Higgins do not have any subscription rights.

At the end of 2022, Stoffels IMC BV (permanently represented by Dr. Paul Stoffels) held 1,000,000 subscription rights, Mr. Bart Filius held 25,000 shares and 373,000 subscription rights, Dr. Walid Abi-Saab held 2,500 shares and 277,000 subscription rights, and Mr. Michele Manto held 2,020 shares and 214,000 subscription rights.

RSUs offered to, vested or expired for the Executive Committee members

In 2022, the Executive Committee members were offered new RSUs under 2022 RSU Annual Long-Term Incentive Plan, except our new CEO who joined per 1 April 2022, and under the 2022 RSU Retention Plan, subject to acceptance. The members of the Executive Committee accepted all RSUs offered to them, except for one member. The grant under the 2022 RSU Annual Long-Term Incentive Plan is the grant equivalent to the actual bonus for 2021 and this RSU grant will vest in full three years after the offer date. The grant under the 2022 RSU Retention Plan has a four-year vesting period, with 25% vesting each year and a first vesting date on 1 May 2023. With the exception of the RSUs offered to and accepted by Stoffels IMC BV (permanently represented by Dr. Paul Stoffels), the RSUs are not transferable. The table below sets forth the total number of RSUs offered and accepted by each Executive Committee member during 2022: Stoffels IMC BV (permanently represented by Dr. Paul Stoffels): 74,408 RSUs, Mr. Bart Filius: 61,442 RSUs, Dr. Walid Abi-Saab: 37,274 RSUs and Mr. Michele Manto: 27,354 RSUs.

The main characteristics of the RSU plans for the Executive Committee members are as follows:

  • The RSUs are offered for no consideration;
  • Three or four year vesting periods apply, as set forth per plan in the table below;
  • In case of termination of service before the vesting date, forfeiture rules apply.

Each RSU represents the right to receive, at Galapagos’ discretion, one Galapagos share or a payment in cash of an amount equivalent to the volume-weighted average price of the Galapagos share on Euronext Brussels over the 30-calendar day period preceding the relevant vesting date. However, in respect of Executive Committee members, any vesting prior to the third anniversary of the offer date will always give rise to a payment in cash rather than a delivery of shares as an incentive.

No RSUs expired during financial year 2022. The table below sets forth the main characteristics of RSU plans issued to the (former) Executive Committee members in 2019, 2020, 2021 and 2022, the number of RSUs awarded to and accepted by each (former) Executive Committee member under the respective RSU Plan, and the number of RSUs vested and paid out to each (former) Executive Committee member during 2022:

Executive Committee member

Plan

Offer date

Vesting period

Vesting date

Number of RSUs offered and accepted

RSUs vested during 2022

Stoffels IMC BV, permanently represented by Dr. Paul Stoffels

Plan 2022.II

05/05/2022

25%/year
Four-year vesting period

01/05/2023
01/05/2024
01/05/2025
01/05/2026

74,408

 

Mr. Onno van de Stolpe(1)

Plan 2019.I

16/10/2019

100% three years after offer date

16/10/2022

15,000

15,000

Plan 2019.II

16/10/2019

25%/year
Four-year vesting period

01/05/2020
01/05/2021
01/05/2022
01/05/2023

25,606

6,401

Plan 2019.III

16/10/2019

50% two years after offer date
50% three years after offer date

16/10/2021
16/10/2022

16,922

8,461

Plan 2020.I

06/05/2020

100% three years after offer date

06/05/2023

2,392

 

Plan 2020.II

06/05/2020

25%/year
Four-year vesting period

01/05/2021
01/05/2022
01/05/2023
01/05/2024

15,925

3,981

Plan 2021.I

05/05/2021

100% three years after offer date

05/05/2024

2,111

 

Plan 2021.IV

24/09/2021

25%/year
Four-year vesting period

01/05/2022
01/05/2023
01/05/2024
01/05/2025

61,719

15,429

Mr. Bart Filius

Plan 2019.I

16/10/2019

100% three years after offer date

16/10/2022

5,000

5,000

Plan 2019.II

16/10/2019

25%/year
Four-year vesting period

01/05/2020
01/05/2021
01/05/2022
01/05/2023

17,924

4,481

Plan 2019.III

16/10/2019

50% two years after offer date
50% three years after offer date

16/10/2021
16/10/2022

16,922

8,461

Plan 2020.I

06/05/2020

100% three years after offer date

06/05/2023

1,452

 

Plan 2020.II

06/05/2020

25%/year
Four-year vesting period

01/05/2021
01/05/2022
01/05/2023
01/05/2024

11,148

2,787

Plan 2021.I

05/05/2021

100% three years after offer date

05/05/2024

1,011

 

Plan 2021.IV

24/09/2021

25%/year
Four-year vesting period

01/05/2022
01/05/2023
01/05/2024
01/05/2025

61,719

15,429

Plan 2022.I

03/05/2022

100% three years after offer date

03/05/2025

3,570

 

Plan 2022.II

05/05/2022

25%/year
Four-year vesting period

01/05/2023
01/05/2024
01/05/2025
01/05/2026

57,872

 

Dr. Andre Hoekema(2)

Plan 2019.I

16/10/2019

100% three years after offer date

16/10/2022

3,000

3,000

Plan 2019.III

16/10/2019

50% two years after offer date
50% three years after offer date

16/10/2021
16/10/2022

16,922

8,461

Plan 2020.I

06/05/2020

100% three years after offer date

06/05/2023

832

 

Plan 2021.IV

24/09/2021

25%/year
Four-year vesting period

01/05/2022
01/09/2022(3)
01/05/2024
01/05/2025

51,433

25,716

Dr. Walid Abi-Saab

Plan 2019.I

16/10/2019

100% three years after offer date

16/10/2022

5,000

5,000

Plan 2019.II

16/10/2019

25%/year
Four-year vesting period

01/05/2020
01/05/2021
01/05/2022
01/05/2023

17,924

4,481

Plan 2019.III

16/10/2019

50% two years after offer date
50% three years after offer date

16/10/2021
16/10/2022

10,153

5,077

Plan 2020.I

06/05/2020

100% three years after offer date

06/05/2023

932

 

Plan 2020.II

06/05/2020

25%/year
Four-year vesting period

01/05/2021
01/05/2022
01/05/2023
01/05/2024

11,148

2,787

Plan 2021.I

05/05/2021

100% three years after offer date

05/05/2024

835

 

Plan 2021.IV

24/09/2021

25%/year
Four-year vesting period

01/05/2022
01/05/2023
01/05/2024
01/05/2025

43,203

10,800

Plan 2022.I

03/05/2022

100% three years after offer date

03/05/2025

2,550

 

Plan 2022.II

05/05/2022

25%/year
Four-year vesting period

01/05/2023
01/05/2024
01/05/2025
01/05/2026

34,724

 

Mr. Michele Manto

Plan 2019.II

16/10/2019

25%/year
Four-year vesting period

01/05/2020
01/05/2021
01/05/2022
01/05/2023

5,121

1,280

Plan 2020.I

06/05/2020

100% three years after offer date

06/05/2023

612

 

Plan 2020.II

06/05/2020

25%/year
Four-year vesting period

01/05/2021
01/05/2022
01/05/2023
01/05/2024

5,308

1,327

Plan 2021.I

05/05/2021

100% three years after offer date

05/05/2024

835

 

Plan 2021.IV

24/09/2021

25%/year
Four-year vesting period

01/05/2022
01/05/2023
01/05/2024
01/05/2025

30,859

7,714

Plan 2022.I

03/05/2022

100% three years after offer date

03/05/2025

2,550

 

Plan 2022.II

05/05/2022

25%/year
Four-year vesting period

01/05/2023
01/05/2024
01/05/2025
01/05/2026

24,804

 

(1)

On the leaver date of Mr. Onno van de Stolpe his unvested RSUs became null and void, being 65,158 RSUs.

(2)

On the leaver date of Dr. Andre Hoekema his unvested RSUs became null and void, being 39,407 RSUs.

(3)

As previously disclosed, upon substantiated recommendation of the Nomination and Remuneration Committee, the Board of Directors approved a deviation of the vesting rules under the RSU Plan 2021.IV. The second vesting of 25% of the RSU grant under the aforementioned plan (corresponding with 12,858 RSUs) has occured earlier than under the normal plan rules.

Pursuant to the terms and conditions of the RSU plans all unvested RSUs of Mr. Onno van de Stolpe and Dr. Andre Hoekema, as set out in the table above, became null and void on their respective retirement date, being 31 October 2022 and 31 December 2022.

In 2023, as part of the Executive Committee's long-term variable remuneration, a number of RSUs equivalent to the 2022 short-term cash bonuses (based on the average share price of the Galapagos share on Euronext Amsterdam during the month of April 2023) will be granted to the members of the Executive Committee under the 2023 RSU Annual Long-Term Incentive Plan (i.e. the long-term portion of the bonus for 2022), except to the retired Chief Executive Officer, Chief Business Officer and Chief Medical Officer.